Skip to content
Assistant Professor
Vivek Dave

Ph.D., University of Maryland
M.S., Bharati Vidyapeeth University, India
B.S., University of Pune, India

Dr. Dave received his bachelor's degree in pharmacy with distinction from University of Pune, India in 2000 and a master's degree in pharmaceutical sciences from Bharati Vidyapeeth University, Pune, India in 2002.

After completion of his master’s degree, Dr. Dave joined Agharkar Research Institute, Pune, India as a junior research fellow. He was involved in a project related to the development and evaluation of anti-arthritis formulations, funded by the Department of Science and Technology, Government of India. Later he worked with Lupin Pharmaceutical Pvt. Ltd. as a research associate.

In 2004, Dr. Dave moved on to pursue Ph.D. in pharmaceutics at the University of Maryland, Baltimore. During his Ph.D., Dr. Dave worked on several research projects including formulation of extended-release matrix tablets via roller-compaction, pre-formulation studies on common pharmaceutical excipients, near-infrared imaging studies to model properties of roller-compacted excipients, and chemometric analysis and development of prediction models with NIR spectroscopy for evaluating functional attributes of extended-release tablet matrices. His research was published in several renowned peer-reviewed scientific journals including International Journal of Pharmaceutics and Drug Development and Industrial Pharmacy. The research was also regularly presented at several professional conferences such as the American Association of Pharmaceutical Scientists (AAPS). While pursuing his Ph.D., Dr. Dave co-authored a chapter on tablet compression and compaction in a widely used reference book.

After graduation in 2009, Dr. Dave accepted a position at Lubrizol Corporation, a specialty chemical company manufacturing pharmaceutical excipients. His role at Lubrizol was to identify, plan, and execute research projects that contributed towards understanding and developing applications for carbomer polymers in pharmaceutical dosage forms.

At St. John Fisher College's Wegmans School of Pharmacy, Dr. Dave is the course coordinator and co-teaches Pharmaceutics-I. He also co-teaches Applied Pharmaceutics. His primary areas of research interests include excipient characterization (physical, chemical, and mechanical), solubility enhancement pre-formulation and formulation aspects of extended-release oral-solid dosage forms, and the use of near-infrared spectroscopy as a Process Analytical Technology (PAT) tool in the Quality by Design (QbD) paradigm.

Dr. Dave also serves as an invited peer reviewer for several scientific journals including Journal of Pharmaceutical Sciences, European Journal of Pharmaceutical Sciences, and Drug Development and Industrial Pharmacy. He is also a member of the American Association of Pharmaceutical Scientists (AAPS), American Association of Colleges of Pharmacy (AACP), and Compaction Simulation Forum (CSF).

Over the years, Dr. Dave has been the recipient of several awards and recognitions including Rho-Chi Honor Society membership, Graduate Student of the Month, Best Poster Presentation, Teacher of the Year (2013), and multiple travel awards.


  • Saoji SD, Atram SC, Dhore PW, Deole PS, Raut NA, Dave VS. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation. AAPS PharmSciTech. 2015. doi: 10.1208/s12249-015-0322-0.
  • Rarokar NR, Saoji SD, Raut NA, Taksande JB, Khedekar PB, Dave VS. Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel. AAPS PharmSciTech. 2015. doi: 10.1208/s12249-015-0369-y.
  • Meng F, Dave V, Chauhan H. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2015;77:106-11. doi: 10.1016/j.ejps.2015.05.018.
  • Dave VS, Saoji SD, Raut NA, Haware RV. Excipient variability and its impact on dosage form functionality. Journal of pharmaceutical sciences. 2015;104(3):906-15. doi: 10.1002/jps.24299.
  • Dave VS, Fahmy RM, Hoag SW. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature. Drug Dev Ind Pharm. 2015;41(6):898-905. doi: 10.3109/03639045.2014.911883.
  • Dave VS, Chanda M, Sayles M, Popielarczyk M, Boyce H, Bompelliwar SK, et al. Correlation of Structural and Macroscopic Properties of Starches with Their Tabletability Using the SM2 Approach. Journal of pharmaceutical sciences. 2015;104(11):3870-82. doi: 10.1002/jps.24601.
  • Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech. 2015;16(4):731-41. doi: 10.1208/s12249-015-0350-9.
  • Dave VS, Fahmy RM, Hoag SW. Investigation of the physical-mechanical properties of Eudragit((R)) RS PO/RL PO and their mixtures with common pharmaceutical excipients. Drug Dev Ind Pharm. 2013;39(7):1113-25. doi: 10.3109/03639045.2012.714786.
  • Dave VS, Fahmy RM, Bensley D, Hoag SW. Eudragit® RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets. Drug Development and Industrial Pharmacy. 2012;38(10):1240-53. doi: 10.3109/03639045.2011.645831.
  • Lim H, Dave VS, Kidder L, Neil Lewis E, Fahmy R, Hoag SW. Assessment of the critical factors affecting the porosity of roller compacted ribbons and the feasibility of using NIR chemical imaging to evaluate the porosity distribution. International journal of pharmaceutics. 2011;410(1-2):1-8. doi: 10.1016/j.ijpharm.2011.02.028.
  • Kale M, Misar AV, Dave V, Joshi M, Mujumdar AM. Anti-inflammatory activity of Dalbergia lanceolaria bark ethanol extract in mice and rats. Journal of ethnopharmacology. 2007;112(2):300-4. doi: 10.1016/j.jep.2007.03.024.